Sponges are prolific
producers of specialized metabolites
with
unique structural scaffolds. Their chemical diversity has always inspired
natural product chemists working in drug discovery. As part of their
metabolic filter-feeding activities, sponges are known to release
molecules, possibly including their specialized metabolites. These
released “Exo-Metabolites” (EMs) may be considered as new chemical reservoirs
that could be collected from the water column while preserving marine
biodiversity. The present work aims to determine the proportion and
diversity of specialized EMs released by the sponge Aplysina cavernicola (Vacelet 1959). This Mediterranean
sponge produces bromo-spiroisoxazoline alkaloids that are widely distributed
in the Aplysinidae family. Aquarium experiments were designed to facilitate
a continuous concentration of dissolved and diluted metabolites from
the seawater around the sponges. Mass Spectrometry (MS)-based metabolomics
combined with a dereplication pipeline were performed to investigate
the proportion and identity of brominated alkaloids released as EMs.
Chemometric analysis revealed that brominated features represented
12% of the total sponge’s EM features. Consequently, a total
of 13 bromotyrosine alkaloids were reproducibly detected as EMs. The
most abundant ones were aerothionin, purealidin L, aerophobin 1, and
a new structural congener, herein named aplysine 1. Their structural
identity was confirmed by NMR analyses following their isolation.
MS-based quantification indicated that these major brominated EMs
represented up to 1.0 ± 0.3% w/w of the concentrated seawater
extract. This analytical workflow and collected results will serve
as a stepping stone to characterize the composition of A. cavernicola’s EMs and those released by
other sponges through in situ experiments, leading
to further evaluate the biological properties of such EMs.